HOME >> BIOLOGY >> NEWS
Wanted: Companies to license life-saving breath test developed at NJIT

Menssana Research, located in the small business incubator program at New Jersey Institute of Technology (NJIT), is seeking companies to license its federally-approved Heartsbreath test, a life-saving technology. Since 1985, Menssana has been developing a unique series of two-minute breath tests. The Heartsbreath Test is the company's first to secure Food and Drug Administration (FDA) approval. Several more tests, including one for lung cancer, are in the pipeline.

The Heartsbreath test determines whether patients with heart transplants are showing signs of rejecting their new heart. It is non-invasive and risk-free. FDA approved the test for clinical use as an adjunct to biopsy.

"We are at the point where it makes sense to interest other companies in licensing this breath test so that it can be sold to hospitals and doctors," said Menssana founder and CEO Michael Phillips, MD. Phillips is a clinical professor of internal medicine at New York Medical College, Valhalla, NY, and a Fort Lee resident. The Enterprise Development Center (EDC) at NJIT, which keeps new technology businesses alive and growing in New Jersey, operates the incubator program.

"One day I hope to see our breath testing equipment, which is relatively small and easy to use, in every physician's office and hospital lab," Phillips added. "Our tests can not only save lives, but they can make medicine less frightening for millions of people," (EDITOR'S NOTE: To interview Phillips either in his lab or by telephone, contact Sheryl Weinstein at 973-596-3436.)

"Doctors have used breath to uncover disease since the time of Hippocrates in Ancient Greece. We've known for more than 2000 years that a diabetic's breath smells fruity, like rotten apples. We now know that it's because of the acetone in their breath. Patients with failing kidneys have breath that smells like urine, and diseases of the liver and the lungs also have distinctive odors. We've taken ancient
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
10-Aug-2005


Page: 1 2 3

Related biology news :

1. Companies license real-time pathogen detection technology developed at Kent State, NEOUCOM
2. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
3. Macrochem acquires option to license pexiganan
4. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics
5. University of Colorado influenza chip licensed by Quidel Corp. of San Diego
6. Rensselaer licenses microscope technology to Thorlabs
7. Columbia University licenses next-generation DNA sequencing technology
8. Case Western Reserve University licenses methoxyamine to Tracon
9. Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan
10. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
11. Yale ovarian cancer detection technology licensed in China by SurExam

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... , ... September 12, 2018 , ... ... spine fusion solutions announced today it has received 510(k) clearance from the U.S. ... complementing its TowerLOX® MIS Pedicle Screw System. , TowerLOX-EXT MIS Extended Tab Pedicle ...
(Date:9/1/2018)... ... ... is hard at work on his second ocean crossing. After becoming the first human to ... to San Francisco, churning his limbs eight hours a day in the cold Pacific for ... its kind, The Swim is far more than just an extreme sport. Besides the gruelling ...
(Date:8/31/2018)... BELLINGHAM, Wash., and CARDIFF, Wales (PRWEB) , ... ... ... European Space Agency. Martha Sanchez, senior scientist, IBM Research. Jacklyn Novak, infrared materials ... that of Katherine Johnson, the NASA mathematician who just celebrated her 100th birthday. ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... , ... August 28, 2018 , ... ... presenting the results of a safety study performed on an allogeneic (donor derived) ... Veterinary Regenerative Medicine Association (NAVRMA) conference in September. He is also the ...
(Date:8/29/2018)... ... , ... USDM Life Sciences , the leading risk management, technological innovation ... Manu Vohra will deliver a presentation at the BoxWorks 2018 conference in ... GxP in 30 Days” , When: Thursday, August 30, 1:00-1:50 PM PT, Where: ...
(Date:8/26/2018)... ... 24, 2018 , ... ExoCoBio Inc., based in South Korea, ... and inhibits a variety of inflammatory targets in the journal of Stem Cell ... having severe atopic dermatitis were significantly improved after administration of stem cell-derived exosomes ...
(Date:8/23/2018)... WHITEHOUSE STATION, N.J. (PRWEB) , ... August 23, 2018 , ... ... Rutgers University by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the ... few years later. , Visikol’s path from an idea to a successful biotech ...
Breaking Biology Technology:
Cached News: